Search Results for: covid-19
Articles
Bormioli Pharma Invests in Type I Glass Vial Production for Injectable Medicines & Vaccines June 29, 2020
The global, Covid-19 pandemic emergency has not weakened Bormioli Pharma's determination to keep on investing and supporting its customers. After...Mateon & GMP Completed Research & Service Agreement June 24, 2020
Mateon Therapeutics, Inc. recently announced that both Golden Mountain Partners (GMP) and Mateon have fulfilled all the obligations under the Research and Services Agreement entered on….
Bionic Sight Doses First Patient in a Phase 1/2 Clinical Trial of a New Investigational Treatment for Blindness June 17, 2020
Bionic Sight, LLC recently announced it has dosed the first patient in the company’s Phase 1/2 clinical trial of BS01, an optogenetic gene therapy for patients with….
Arch Biopartners Announces FDA Acknowledgement of its IND Application June 17, 2020
Arch Biopartners Inc. recently announced the US FDA has received and acknowledged the Investigational New Drug (IND) Application for its...Phathom Pharmaceuticals Provides Clinical Trial Status Update June 17, 2020
Phathom Pharmaceuticals, Inc. recently announced it has randomized the first new patients in each of its two Phase 3 clinical...Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial June 10, 2020
Precision BioSciences, Inc. recently announced that the first patient has been dosed in a Phase 1/2a clinical trial of PBCAR269A,...Arch Biopartners Submits IND Application to the FDA for Metablok (LSALT Peptide) June 10, 2020
Arch Biopartners Inc. recently announced it has submitted an Investigational New Drug (IND) Application to the US FDA for its...SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Specialized Capabilities for Small & Large Molecules June 4, 2020
Contributor Cindy H. Dubin interviews key players in the CDMO market who present case studies about how they are helping pharmaceutical and biopharma companies overcome a variety of formulation and manufacturing challenges.
CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement June 2, 2020
CordenPharma recently announced the signing of an amendment to their existing manufacturing agreement with Moderna, Inc., a clinical stage biotechnology...Taconic Biosciences Launches Rapid Restart Program May 19, 2020
Taconic Biosciences, a global leader in providing drug discovery animal model solutions, recently announced the successful implementation of its Rapid Restart program….
Rubius Therapeutics Announces Dosing of First Patient in Phase 1/2 Trial May 13, 2020
Rubius Therapeutics, Inc. recently announced that the first patient has been dosed in its Phase 1/2 clinical trial of RTX-240...Fortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University May 13, 2020
Fortress Biotech, Inc. recently announced that Oncogenuity, Inc. has entered into an exclusive worldwide licensing agreement with Columbia University to develop novel….
Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership With CytoDyn May 5, 2020
Ajinomoto Bio-Pharma Services recently announced it has entered into a manufacturing services agreement with CytoDyn Inc., a late stage biotechnology company, for the supply of the investigational new drug….
3M Drug Delivery Systems Launches as Independent Company, Kindeva Drug Delivery May 5, 2020
Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, recently announced its launch as an independent company following the acquisition by Altaris Capital Partners in a transaction valued at….
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial April 9, 2020
Precision BioSciences, Inc. recently announced the initiation of patient dosing in a Phase 1/2a clinical trial of its second off-the-shelf (allogeneic) chimeric….
Antiviral Drugs Market to Foresee Tremendous Gains Over 2020-2026 April 9, 2020
The global antiviral drugs market was valued at $56 billion in 2019 and is expected to accrue phenomenal gains over...Aravive Announces AVB-500 Improves Anti-Tumor Effects When Combined With Anti-Angiogenic Bevacizumab or PARP Inhibitor Olaparib April 1, 2020
Aravive, Inc. recently announced that AVB-500 improves anti-tumor effects when combined with the anti-angiogenic bevacizumab or the PARP inhibitor olaparib...Carterra Selected by La Jolla Institute of Immunology to Provide Antibody Screening & Characterization for the Coronavirus Immunotherapy Consortium (CoVIC) April 1, 2020
Carterra Inc. and La Jolla Institute for Immunology (LJI), announced today that they will use Carterra’s proprietary LSA platform to...Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate From Premas Biotech March 25, 2020
Akers Biosciences, Inc. recently announced it has acquired a licensing agreement with Premas Biotech, under which Akers will in-license a novel coronavirus vaccine candidate under development by…..
WPD Pharmaceuticals Partners With CNS Pharmaceuticals on Drug Development for Coronavirus & Other Antiviral Indications March 25, 2020
WPD Pharmaceuticals Inc. recently announced it has entered into a development agreement with CNS Pharmaceuticals, Inc. for the development of……
